GlassScriptPhysician profile
Russell A Beck
NPI 1578672671
$1,573.82
in general payments reported to CMS, 2019-2025
27 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.70 · 2020: $79.49 · 2021: $201 · 2022: $344 · 2023: $424 · 2024: $295 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $865.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $342.73 | 2019-2023 | Liletta, Lo Loestrin Fe |
| Stryker Corporation | $148.46 | 2024 | |
| Mayne Pharma Commercial LLC | $124.42 | 2022-2024 | |
| Organon LLC | $108.39 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $72.42 | 2020-2023 | |
| Myriad Women'S Health, INC. | $71.16 | 2023 | Myrisk |
| Hologic Sales and Service, LLC | $70.23 | 2019-2023 | Aptima, Thinprep 2000 Processor |
| Coopersurgical, INC. | $66.84 | 2022-2024 | Paragard T 380a |
| Myovant Sciences INC. | $63.75 | 2022 | |
| Pfizer INC. | $59.77 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $55.76 | 2023 | Myfembree |
| Daiichi Sankyo INC. | $52.48 | 2019-2021 | |
| Biogen, INC. | $49.19 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $41.20 | 2020-2021 | |
| Shield Therapeutics INC | $33.33 | 2022-2023 | Accrufer |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $24.76 | 2023 | Dexcom G6 Transmitter |
| Aspira Women'S Health INC | $22.34 | 2023 | Ova1 |
| Boston Scientific Corporation | $19.72 | 2025 | Lithovue Elite |
| Exeltis, USA INC. | $19.28 | 2022 | |
| Baxter Healthcare | $19.16 | 2024 | Perclot |
| Minerva Surgical, INC | $18.00 | 2019 | |
| Agile Therapeutics, INC. | $17.99 | 2023 | Twirla |
| Optumhealth Care Solutions, LLC | $16.87 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Millicent US INC | $16.02 | 2020 | |
| Smith+Nephew, INC. | $15.48 | 2025 | Pico 7, Pico 14 |
| Cook Medical LLC | $13.36 | 2023 | Cook |
| Meditrina | $10.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.